Publikationen von F. Holsboer

Ströhle, A.; Kellner, M.; Holsboer, F.; Wiedemann, K.: Behavioral, neuroendocrine and cardiovascular response to flumazenil: No evidence for an altered benzodiazepine receptor sensitivity in panic disorder - Reply. Biological Psychiatry 46, S. 1710 - 1711 (1999)

Ströhle, A.; Romeo, E.; Hermann, B.; di Michelle, F.; Spaletta, G.; Pasini, A.; Holsboer, F.; Rupprecht, R.: Concentrations of 3α-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biological Psychiatry 45, S. 274 - 277 (1999)

Then Bergh, F.; Grasser, A.; Trenkwalder, C.; Backmund, H.; Holsboer, F.; Rupprecht, R.: Binding characteristics of the glucocorticoid receptor in peripheral blood lymphocytes in multiple sclerosis. Journal of Neurology 246, S. 292 - 298 (1999)

Then Bergh, F.; Kümpfel, T.; Trenkwalder, C.; Rupprecht, R.; Holsboer, F.: Dysregulation of the hypothalamic-pituitary-adrenal axis is related to the clinical course of multiple sclerosis. Neurology 53, S. 772 - 777 (1999)

Wetzel, C. H. R.; Vedder, H.; Holsboer, F.; Zieglgänsberger, W.; Deisz, R. A.: Bidirectional effects of the neuroactive steroid tetrahydrodeoxycorticosterone on GABA-activated Cl^- currents in cultured rat hypothalamic neurons. British Journal of Pharmacology 127, S. 863 - 868 (1999)

Zobel, A. W.; Yassouridis, A.; Frieboes, R.-M.; Holsboer, F.: Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression. American Journal of Psychiatry 156, S. 949 - 951 (1999)

Arzt, E.; Paez Pereda, M.; Costas, M.; Sauer, J.; Renner, U.; Holsboer, F.; Stalla, G. K.: Cytokine expression and molecular mechanisms of their autocrine/paracrine regulation of anterior pituitary function and growth. Annals New York Academy of Sciences 840, S. 525 - 531 (1998)

Behl, C.; Holsboer, F.: Oxidativer Stress in der Pathogenese von Morbus Alzheimer und antioxidative Neuroprotektion. Fortschritte der Neurologie/Psychiatrie 66, S. 113 - 121 (1998)

Dijkstra, I.; Tilders, F. J. H.; Aguilera, G.; Kiss, A.; Rabadan-Diehl, C.; Barden, N.; Karanth, S.; Holsboer, F.; Reul, J. M. H. M.: Reduced activity of hypothalamic corticotropin-releasing hormone neurons in transgenic mice with impaired glucocorticoid receptor function. Journal of Neuroscience 18, S. 3903 - 3918 (1998)

Engelmann, M.; Landgraf, R.; Lörscher, P.; Conzelmann, C.; Probst, J. C.; Holsboer, F.; Reul, J. M. H. M.: Downregulation of brain mineralocorticoid and glucocorticoid receptor by antisense oligodeoxynucleotide treatment fails to alter spatial navigation in rats. European Journal of Pharmacology 361, S. 17 - 26 (1998)

Hemmeter, U.; Rothe, B.; Guldner, J.; Holsboer, F.; Steiger, A.: Effects of thyreotropin-releasing hormone on the sleep EEG and nocturnal hormone secretion in male volunteers. Neuropsychobiology 38, S. 25 - 31 (1998)

Heuser, I.; Bissette, G.; Dettling, M.; Schweiger, U.; Gotthardt, U.; Schmider, J.; Lammers, C.-H.; Nemeroff, C. B.; Holsboer, F.: Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin and somatostatin in depressed patients and healthy controls: Response to amitriptyline treatment. Depression 8, S. 71 - 79 (1998)

Hinze-Selch, D.; Becker, E. W.; Stein, G. M.; Berg, P. A.; Mullington, J.; Holsboer, F.; Pollmächer, T.: Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients. Neuropsychopharmacology 19, S. 114 - 122 (1998)

Hinze-Selch, D.; Wetter, T. C.; Zhang, Y.; Lu, H. C.; Albert, E. D.; Mullington, J.; Wekerle, H.; Holsboer, F.; Pollmächer, T.: In vivo and in vitro immune variables in patients with narcolepsy and HLA-DR2 matched controls. Neurology 50, S. 1149 - 1152 (1998)

Holsboer, F.: Wirkmechanismen der Antidepressiva. Jatros Neurologie - Psychiatrie und Psychotherapie 3, S. 12 - 22 (1998)

Kovalovsky, D.; Paez Pereda, M.; Sauer, J.; Perez Casto, C.; Nahmod, V. E.; Stalla, G. K.; Holsboer, F.; Arzt, E.: The Th1 and Th2 cytokines IFN-y and IL-4 antagonize the inhibition of monocyte IL-1 receptor antagonist by glucocorticoids: involvement of IL-1. European Journal of Immunology 28, S. 2075 - 2085 (1998)

Lancel, M.; Faulhaber, J.; Holsboer, F.; Rupprecht, R.: The GABA_A receptor antagonist picrotoxin attenuates most of the sleep changes induced by progesterone. Psychopharmacology 141, S. 213 - 219 (1998)

Lauer, C. J.; Schreiber, W.; Modell, S.; Holsboer, F.; Krieg, J.-C.: Die Münchner Vulnerabilitätsstudie zu affektiven Erkrankungen: Überblick über die Ergebnisse der Index-Untersuchung. Nervenarzt 69, S. 574 - 585 (1998)

Lauer, C. J.; Schreiber, W.; Modell, S.; Holsboer, F.; Krieg, J.-C.: The Munich Vulnerability Study on Affective Disorders.: Overview of the cross-sectional observations at index assessment. Journal of Psychiatric Research 32, S. 393 - 401 (1998)

Lauer, C. J.; Zerssen, D. v.; Schreiber, W.; Modell, S.; Holsboer, F.; Krieg, J.-C.: The premorbid psychometric profile is stable over time in subjects at high familial risk for affective disorders. Journal of Affective Disorders 51, S. 45 - 53 (1998)